Azenta Newsroom

Azenta Raised to Overweight From Equal-Weight by Stephens & Co.

Dow JonesDec 18 23:41

Azenta Analyst Ratings

BenzingaDec 18 23:32

Stephens Upgrades Azenta(AZTA.US) to Buy Rating, Raises Target Price to $60

Futu NewsDec 18 20:31

Azenta Is Maintained at Buy by Needham

Dow JonesNov 13 21:48

Azenta Analyst Ratings

BenzingaNov 13 21:38

Needham Maintains Azenta(AZTA.US) With Buy Rating, Cuts Target Price to $55

Futu NewsNov 13 19:31

Azenta Is Maintained at In-Line by Evercore ISI Group

Dow JonesOct 2 00:25

Azenta Analyst Ratings

BenzingaOct 2 00:14

Evercore Maintains Azenta(AZTA.US) With Hold Rating, Cuts Target Price to $50

Futu NewsOct 1 21:34

Azenta Analyst Ratings

BenzingaAug 7 18:19

Needham Reiterates Buy on Azenta, Maintains $69 Price Target

BenzingaAug 7 18:19

Buy Rating Justified by Azenta's Strong Q3 Performance and Growth Potential

TipRanksAug 7 18:10

Azenta Analyst Ratings

BenzingaJul 2 23:00

Evercore ISI Group Maintains In-Line on Azenta, Raises Price Target to $53

BenzingaJul 2 23:00

Analysts Offer Insights on Healthcare Companies: Green Thumb Industries (OtherGTBIF) and Azenta (AZTA)

TipRanksMay 9 17:55

Azenta Analyst Ratings

BenzingaMay 9 17:55

Needham: Maintaining the Azenta (AZTA.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $75.00 to $75.00.

Zhitong FinanceApr 9 07:41

Azenta Analyst Ratings

BenzingaApr 9 07:40

Optimistic Financial Future and Strategic Growth: A Buy Rating for Azenta

TipRanksApr 9 04:10

Analysts Conflicted on These Healthcare Names: Icon (ICLR), Schrodinger (SDGR) and Azenta (AZTA)

TipRanksApr 4 20:25